Home Newsfeeds Maxim Group Downgrades Kintara Therapeutics to Hold

Maxim Group Downgrades Kintara Therapeutics to Hold

Maxim Group analyst Jason McCarthy downgrades Kintara Therapeutics (NASDAQ:KTRA) from Buy to Hold.

byBenzinga Newsdesk

September 29, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades Kintara Therapeutics (NASDAQ:KTRA) from Buy to Hold.

EXCLUSIVE: Marathon Digital CEO Fred Thiel Says FTX Bankruptcy ‘Has Increased The Fear Factor’

By Bibhu Pattnaik

November 12, 1:02 PM

The CEO of Bitcoin (CRYPTO: BTC) mining company Marathon Digital Holdings Inc (NASDAQ: MARA), the world's second-largest holder of Bitcoin among publicly-listed companies, is speaking out about

BTC

What’s Going On With Reliance Global Stock?

By Erica Kollmann

June 18, 11:11 AM

Reliance Global shares are trading higher Tuesday after the company provided an update on the pending acquisition of Spetner Associates. Here's a look at what's going on:

RELI

Reported Late Monday, Biophytis Publishes Its Unaudited Financial Figures; Cash Position At €19.7M As Of June 30, 2022 Compared To €23.9M As Of December 31, 2021

By Benzinga Newsdesk

November 1, 12:41 AM

Biophytis SA (NASDAQ:BPTS)(PARIS:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes

BPTS

Ripple CEO Keeps IPO Option Open, Calls Gary Gensler A ‘Political Liability’

By Mehab Qureshi

January 16, 11:54 PM

Ripple (CRYPTO: XRP) CEO Brad Garlinghouse criticized Securities and Exchange Commission (SEC) Chair Gary Gensler, characterizing his position on crypto regulation as rigid and counterproductive.

$XRP

Maxim Group Downgrades Kintara Therapeutics to Hold

Related Posts

EXCLUSIVE: Marathon Digital CEO Fred Thiel Says FTX Bankruptcy ‘Has Increased The Fear Factor’

What’s Going On With Reliance Global Stock?

Reported Late Monday, Biophytis Publishes Its Unaudited Financial Figures; Cash Position At €19.7M As Of June 30, 2022 Compared To €23.9M As Of December 31, 2021

Ripple CEO Keeps IPO Option Open, Calls Gary Gensler A ‘Political Liability’